Increlex
About Increlex
Increlex is a Healthcare company, and was acquired by Eton Pharmaceuticals in December 2024. Its focus areas include Pharmaceutical Product Websites. Its legal entity is Eton Pharmaceuticals, Inc.
- Stage Acquired
- SectorsHealthcare
- Website category Health · Pharmacy
- Website increlex.com/en-us
- Social LinkedIn YouTube
- Acquired by Eton Pharmaceuticals (Dec 2024)
- Legal Name Eton Pharmaceuticals, Inc
- Investors
- Acquired byEton Pharmaceuticals
(Dec 2024)
Apps and channels of Increlex
its YouTube channel Increlex® (mecasermin) has 24 subscribers and 11 videos.
Videos from Increlex
The most watched videos on Increlex's YouTube channel, Increlex® (mecasermin) (24 subscribers). Click a video to play it here.
More on Increlex® (mecasermin) .
Investors in Increlex
Increlex has secured backing from 1 investor. Prominent investors backing the company include Eton Pharmaceuticals.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Sterile injectables are developed and commercialized by Eton Pharmaceuticals. | 2013 | etonpharma.com | Barrington, United States |
Investor details for Increlex
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Web traffic of Increlex
The website of Increlex (increlex.com) receives about 1.9K visits a month and ranks #5,508,119 among all websites worldwide, #4,801 in Pharmacy.
- Monthly visits1.9K
▼ 36.5% vs previous month
- Unique visitors1.2K
per month
- Global rank#5,508,119
among all websites
- Category rank#4,801
Health · Pharmacy
- Bounce rate39%
- Pages per visit1.7
- Average visit28 sec
- DevicesDesktop 28% · Mobile 72%
Websites whose visitors overlap most with Increlex. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
orencia.com | orencia.com | 100% | #1,512,669 | – | |
zevalin.com | zevalin.com | 63% | – | ||
| adienne.com | 62% | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Increlex
Increlex has 1 investor. Key investors include Eton Pharmaceuticals.
Increlex operates through Eton Pharmaceuticals, Inc.
Yes. Increlex was acquired by Eton Pharmaceuticals in December 2024.